Xingrong Du
- Immunology top 10%
- Molecular Biology
- Cell Biology top 5%
- Oncology
- Cancer Research
- Topics
- Immune Cell Function and Interaction (5 papers)Hippo pathway signaling and YAP/TAZ (5 papers)Immunotherapy and Immune Responses (4 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Xingrong Du
21 papers receiving 774 citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Immunology 344
- Molecular Biology 330
- Cell Biology 247
- Oncology 136
- Cancer Research 120
Countries citing papers authored by Xingrong Du
This map shows the geographic impact of Xingrong Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingrong Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingrong Du more than expected).
Fields of papers citing papers by Xingrong Du
This network shows the impact of papers produced by Xingrong Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingrong Du. The network helps show where Xingrong Du may publish in the future.
Co-authorship network of co-authors of Xingrong Du
This figure shows the co-authorship network connecting the top 25 collaborators of Xingrong Du. A scholar is included among the top collaborators of Xingrong Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingrong Du. Xingrong Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 22 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 13 | |
| 6 | 24 | |
| 7 | 2 | |
| 8 | 1 | |
| 9 | SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunitybreakdown → | 154 |
| 10 | 3 | |
| 11 | 3 | |
| 12 | 53 | |
| 13 | 11 | |
| 14 | 37 | |
| 15 | 141 | |
| 16 | 49 | |
| 17 | 17 | |
| 18 | 21 | |
| 19 | 22 | |
| 20 | 89 |
About Xingrong Du
Xingrong Du is a scholar working on Cell Biology, Immunology and Reproductive Medicine, having authored 22 papers that have together received 781 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (5 papers), Hippo pathway signaling and YAP/TAZ (5 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Immunology (344 citations), Cell Biology (247 citations) and Cancer Research (120 citations). Xingrong Du has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Hongbo Chi, Wufan Tao, Hao Shi, Yogesh Dhungana, Cliff Guy, Tian Xu, Nicole M. Chapman, Yongli Dong, Yuan Zhuang and Jian Ye. Their work appears in journals such as Nature, Journal of Biological Chemistry and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.